Experts said India does not have to choose between innovation and affordability. Instead, they called for public resources to focus on therapies that offer the greatest public health benefit

The Supreme Court of India has warned against unapproved stem cell therapy for autism, allowing it only in approved clinical trials, and urged action against misleading claims, while experts recommend supportive therapies as effective alternatives